Post

FDA grants orphan drug status to NovelMed’s PNH treatment

NovelMed has announced the receipt of orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its …

India sees insignificant revision to price ceiling in 2024

India's independent drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), has issued a marginal increase of 0.0055% to the …

Norgine seeks approval for high-risk neuroblastoma treatment

Norgine has sought approval for eflornithine (difluoromethylornithine [DFMO]) for the treatment of patients with high-risk neuroblastoma (HRNB). The development marks the …

Sanofi signs mRNA vaccine development deal with IDT Australia

Sanofi has signed a master service agreement with IDT Australia focusing on the preclinical formulation development and current Good Manufacturing …

The cutting-edge monitoring technology that is transforming the future of clinical trials

As the pharmaceutical landscape evolves, the complexity that these innovations require for their supply chains also increases. The development of …